In 1932, a group of homeopathic physicians in France were searching for a reliable source for their homeopathic medicines. At their request, pharmacist twin brothers Jean and Henri Boiron founded the pharmaceutical company that was to become world leader in homeopathic medicines. Today, Boiron is a $741 million public company with 3,900 employees and distribution in more than 60 countries. It is best known for Oscillococcinum®, a top-selling flu medicine, and its Arnicare® line of pain relievers.
For more than 80 years, Boiron has been committed to funding scientific research and educating the public and health care professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.